Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor δ with head and neck squamous cell carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 127, Issue 10, 2001, Pages 1253-1259

  Jaeckel, Elise C ^a   Raja, Shefali ^a   Tan, Jian ^a   Das, Sanjoy K ^a   Dey, Sudhansu K ^a   Girod, Douglas A ^a   Tsue, Terrance T ^a   Sanford, Thomas R ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTACYCLIN; PROSTAGLANDIN; VASCULOTROPIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; ENDOPLASMIC RETICULUM; ENZYME INDUCTION; ENZYME SUBSTRATE; GENE EXPRESSION REGULATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MEDIATOR RELEASE; TUMOR VOLUME;

EID: 0034779322     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.127.10.1253     Document Type: Article

References (32)

1. Prostaglandins in squamous cell carcinoma of the head and neck. A preliminary study
2. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
3. Prostaglandins in carcinomas of the head and neck
4. 2 of the upper aerodigestive tract
5. Larynx cancer prostaglandins
6. Delay in hamster buccal pouch carcinogenesis by aspirin indomethacin
7. Inhibition of cyclooxygenase. A novel approach to cancer prevention
8. Oral mucosal tumor inhibition by ibuprofen
9. Prevention of secondary primary tumors with isotretinoin in squamous cell carcinoma of the head neck
10. Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal anti-inflammatory drugs
11. Prostaglandin endoperoxide H synthase-1-2
12. Cyclooxygenase in biology disease
13. Cyclooxygenases 1-2
14. Multiple female reproductive failures in cyclooxygenase-2-deficient mice
15. Characterization of cyclooxygenase in laryngeal papilloma by molecular techniques
16. Peroxisome proliferator-activated receptors (PPARs) carcinogenesis
17. Peroxisome proliferator-activated receptor δ induces growth arrest differentiation markers of human colon cancer cells
18. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ
19. Host cyclooxygenase-2 modulates carcinoma growth
20. Vascular endothelial growth factor stimulates prostacyclin production activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogenactivated protein kinase
21. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide prostacyclin
22. Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line rat lungs via cAMP
23. Heparin-binding growth factor(s) derived from head and neck squamous cell carcinomas induce endothelial cell proliferation
24. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head neck
25. Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma dysplasia
26. Regulation of the ontogeny rat liver metallothionein by zinc
27. Differential expression of vascular endothelial growth factor its receptor mRNAs in the mouse uterus around the time of implantation
28. Developmental expression of the cyclooxygenase-1, cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst ovarian steroids
29. Amphiregulin is an implantation-specific progesterone-regulated gene in the mouse uterus
30. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
31. Systemic biosynthesis of prostacyclin by cyclooxygenase(COX)-2. The human pharmacology of a selective inhibitor of COX-2
32. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs